Effects of High Anxiety Scores on Surgical and Overall Treatment Plan in Patients with Breast Cancer Treated with Neoadjuvant Therapy.
Nathalie LeVasseurHuaqi LiWinson CheungPaula MyersElaine MckevittRebecca WarburtonKaylie-Anne WillemsmaAdam Deruchie TanStephen ChiaChristine SimmonsPublished in: The oncologist (2019)
The prevalence of anxiety among women with newly diagnosed breast cancer is being increasingly acknowledged. However, health care providers have not fully appreciated the impact of anxiety on the surgical management of patients with early-stage breast cancer. This study highlights the importance of self-reported anxiety on surgical management. The preoperative period provides a unique window of opportunity to address sources of anxiety and provide targeted educational materials over a period of 4-6 months, which may ultimately lead to less aggressive surgery when it is not needed.
Keyphrases
- sleep quality
- early stage
- newly diagnosed
- healthcare
- minimally invasive
- risk factors
- squamous cell carcinoma
- patients undergoing
- mesenchymal stem cells
- drinking water
- cancer therapy
- percutaneous coronary intervention
- coronary artery disease
- neoadjuvant chemotherapy
- physical activity
- smoking cessation
- drug delivery
- combination therapy
- replacement therapy
- affordable care act